Incorrect mate please see page 2 MSB state 14th
Request for trading halt for Mesoblast Limited (ASX: MSB)
Pursuant to ASX Listing Rule 17.1, Mesoblast Limited ACN 109 431 870 (ASX: MSB; NASDAQ:
MESO) (the Company) requests a trading halt in its securities effective immediately pending an
announcement by the Company in relation to the upcoming meeting of the Oncologic Drugs
Advisory Committee of the United States Food and Drug Administration.
For the purposes of Listing Rule 17.1, the Company provides the following information:
(a) the trading halt is requested pending an announcement in relation to the matters
above;
(b) the Company requests that the trading halt continues until it makes an announcement
regarding the matters above which is expected to be on Friday, 14 August 2020; and
(c) the Company is not aware of any reason why the trading halt should not be granted or
of any other information necessary to inform the market about the trading halt.
Ann: Trading Halt, page-57
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.40 |
Change
0.045(3.33%) |
Mkt cap ! $1.592B | |||
| Open | High | Low | Value | Volume |
| $1.35 | $1.42 | $1.33 | $3.802M | 2.753M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 23940 | $1.39 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.40 | 22571 | 2 |
View Market Depth
| Last trade - 16.10pm 08/11/2024 (20 minute delay) ? |
| MSB (ASX) Chart |